Exponent (EXPO) Competitors

$54.04 +0.38 (+0.70%)

As of 11:02 AM Eastern

EXPO vs. VSEC, FCN, IHS, HURN, and CBZ

Should you buy Exponent stock or one of its competitors? MarketBeat compares Exponent with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Exponent include VSE (VSEC), FTI Consulting (FCN), IHS (IHS), Huron Consulting Group (HURN), and CBIZ (CBZ). These companies are all part of the "research & consulting services" industry.

How does Exponent compare to VSE?

VSE (NASDAQ:VSEC) and Exponent (NASDAQ:EXPO) are both mid-cap research & consulting services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, media sentiment, valuation and dividends.

Exponent has a net margin of 18.07% compared to VSE's net margin of 4.95%. Exponent's return on equity of 27.94% beat VSE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
VSE	4.95%	6.56%	4.68%
Exponent	18.07%	27.94%	14.59%

In the previous week, Exponent had 5 more articles in the media than VSE. MarketBeat recorded 10 mentions for Exponent and 5 mentions for VSE. VSE's average media sentiment score of 0.60 beat Exponent's score of 0.02 indicating that VSE is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
VSE	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Exponent	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

VSE presently has a consensus target price of $239.13, indicating a potential upside of 38.43%. Exponent has a consensus target price of $85.00, indicating a potential upside of 57.28%. Given Exponent's higher probable upside, analysts plainly believe Exponent is more favorable than VSE.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VSE	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	3.00
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

VSE pays an annual dividend of $0.40 per share and has a dividend yield of 0.2%. Exponent pays an annual dividend of $1.24 per share and has a dividend yield of 2.3%. VSE pays out 16.9% of its earnings in the form of a dividend. Exponent pays out 57.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Exponent has raised its dividend for 12 consecutive years. Exponent is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

91.5% of VSE shares are owned by institutional investors. Comparatively, 92.4% of Exponent shares are owned by institutional investors. 1.8% of VSE shares are owned by insiders. Comparatively, 1.6% of Exponent shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Exponent has lower revenue, but higher earnings than VSE. Exponent is trading at a lower price-to-earnings ratio than VSE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VSE	$1.11B	4.36	$11.70M	$2.37	72.88
Exponent	$582.01M	4.50	$106.01M	$2.15	25.14

VSE has a beta of 1.25, meaning that its stock price is 25% more volatile than the broader market. Comparatively, Exponent has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market.

Summary

VSE and Exponent tied by winning 10 of the 20 factors compared between the two stocks.

How does Exponent compare to FTI Consulting?

Exponent (NASDAQ:EXPO) and FTI Consulting (NYSE:FCN) are both mid-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

Exponent has a net margin of 18.07% compared to FTI Consulting's net margin of 6.88%. Exponent's return on equity of 27.94% beat FTI Consulting's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exponent	18.07%	27.94%	14.59%
FTI Consulting	6.88%	15.14%	7.63%

In the previous week, Exponent had 2 more articles in the media than FTI Consulting. MarketBeat recorded 10 mentions for Exponent and 8 mentions for FTI Consulting. FTI Consulting's average media sentiment score of 0.93 beat Exponent's score of 0.02 indicating that FTI Consulting is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exponent	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
FTI Consulting	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Exponent presently has a consensus target price of $85.00, indicating a potential upside of 57.28%. FTI Consulting has a consensus target price of $180.00, indicating a potential upside of 23.61%. Given Exponent's stronger consensus rating and higher possible upside, analysts plainly believe Exponent is more favorable than FTI Consulting.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
FTI Consulting	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

92.4% of Exponent shares are owned by institutional investors. Comparatively, 99.4% of FTI Consulting shares are owned by institutional investors. 1.6% of Exponent shares are owned by insiders. Comparatively, 1.8% of FTI Consulting shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

FTI Consulting has higher revenue and earnings than Exponent. FTI Consulting is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exponent	$582.01M	4.50	$106.01M	$2.15	25.14
FTI Consulting	$3.79B	1.16	$270.87M	$8.41	17.32

Summary

Exponent beats FTI Consulting on 9 of the 15 factors compared between the two stocks.

How does Exponent compare to IHS?

Exponent (NASDAQ:EXPO) and IHS (NYSE:IHS) are both mid-cap research & consulting services companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations.

Exponent presently has a consensus target price of $85.00, indicating a potential upside of 57.28%. IHS has a consensus target price of $9.61, indicating a potential upside of 16.80%. Given Exponent's stronger consensus rating and higher possible upside, analysts plainly believe Exponent is more favorable than IHS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
IHS	1 Sell rating(s)	5 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.22

Exponent has a beta of 0.78, indicating that its share price is 22% less volatile than the broader market. Comparatively, IHS has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market.

IHS has higher revenue and earnings than Exponent. IHS is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exponent	$582.01M	4.50	$106.01M	$2.15	25.14
IHS	$1.58B	1.74	$143.60M	$0.41	20.06

Exponent has a net margin of 18.07% compared to IHS's net margin of 10.74%. Exponent's return on equity of 27.94% beat IHS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exponent	18.07%	27.94%	14.59%
IHS	10.74%	-1,351.44%	12.81%

In the previous week, Exponent had 5 more articles in the media than IHS. MarketBeat recorded 10 mentions for Exponent and 5 mentions for IHS. Exponent's average media sentiment score of 0.02 beat IHS's score of -0.33 indicating that Exponent is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exponent	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
IHS	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

92.4% of Exponent shares are owned by institutional investors. Comparatively, 17.5% of IHS shares are owned by institutional investors. 1.6% of Exponent shares are owned by insiders. Comparatively, 1.1% of IHS shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Exponent beats IHS on 13 of the 16 factors compared between the two stocks.

How does Exponent compare to Huron Consulting Group?

Huron Consulting Group (NASDAQ:HURN) and Exponent (NASDAQ:EXPO) are both business services companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.

Huron Consulting Group currently has a consensus target price of $205.50, indicating a potential upside of 92.45%. Exponent has a consensus target price of $85.00, indicating a potential upside of 57.28%. Given Huron Consulting Group's stronger consensus rating and higher possible upside, equities research analysts plainly believe Huron Consulting Group is more favorable than Exponent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Huron Consulting Group	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

Huron Consulting Group has a beta of 0.15, indicating that its stock price is 85% less volatile than the broader market. Comparatively, Exponent has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market.

Exponent has lower revenue, but higher earnings than Huron Consulting Group. Huron Consulting Group is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Huron Consulting Group	$1.70B	1.02	$105.04M	$5.86	18.22
Exponent	$582.01M	4.50	$106.01M	$2.15	25.14

Exponent has a net margin of 18.07% compared to Huron Consulting Group's net margin of 5.94%. Huron Consulting Group's return on equity of 29.41% beat Exponent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Huron Consulting Group	5.94%	29.41%	9.10%
Exponent	18.07%	27.94%	14.59%

In the previous week, Exponent had 3 more articles in the media than Huron Consulting Group. MarketBeat recorded 10 mentions for Exponent and 7 mentions for Huron Consulting Group. Huron Consulting Group's average media sentiment score of 0.20 beat Exponent's score of 0.02 indicating that Huron Consulting Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Huron Consulting Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Exponent	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

93.9% of Huron Consulting Group shares are held by institutional investors. Comparatively, 92.4% of Exponent shares are held by institutional investors. 2.1% of Huron Consulting Group shares are held by company insiders. Comparatively, 1.6% of Exponent shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Huron Consulting Group beats Exponent on 9 of the 16 factors compared between the two stocks.

How does Exponent compare to CBIZ?

CBIZ (NYSE:CBZ) and Exponent (NASDAQ:EXPO) are both business services companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.

Exponent has a net margin of 18.07% compared to CBIZ's net margin of 5.57%. Exponent's return on equity of 27.94% beat CBIZ's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CBIZ	5.57%	12.62%	5.17%
Exponent	18.07%	27.94%	14.59%

CBIZ has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market. Comparatively, Exponent has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market.

87.4% of CBIZ shares are held by institutional investors. Comparatively, 92.4% of Exponent shares are held by institutional investors. 4.1% of CBIZ shares are held by company insiders. Comparatively, 1.6% of Exponent shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

CBIZ currently has a consensus target price of $37.33, indicating a potential upside of 30.05%. Exponent has a consensus target price of $85.00, indicating a potential upside of 57.28%. Given Exponent's stronger consensus rating and higher possible upside, analysts plainly believe Exponent is more favorable than CBIZ.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CBIZ	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.43
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50

CBIZ has higher revenue and earnings than Exponent. CBIZ is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CBIZ	$2.76B	0.56	$115.44M	$2.49	11.53
Exponent	$582.01M	4.50	$106.01M	$2.15	25.14

In the previous week, Exponent had 7 more articles in the media than CBIZ. MarketBeat recorded 10 mentions for Exponent and 3 mentions for CBIZ. CBIZ's average media sentiment score of 0.54 beat Exponent's score of 0.02 indicating that CBIZ is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CBIZ	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Exponent	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Summary

Exponent beats CBIZ on 9 of the 16 factors compared between the two stocks.

Get Exponent News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EXPO vs. The Competition

Export

Metric	Exponent	Consulting Industry	Business Sector	NASDAQ Exchange
Market Cap	$2.63B	$4.03B	$6.40B	$12.28B
Dividend Yield	2.27%	2.71%	3.18%	5.35%
P/E Ratio	25.21	13.95	30.60	25.35
Price / Sales	4.50	1.95	437.16	73.28
Price / Cash	23.44	17.31	23.10	56.33
Price / Book	7.75	13.03	6.74	6.86
Net Income	$106.01M	$251.10M	$200.71M	$333.62M
7 Day Performance	-12.01%	-7.64%	2.12%	0.13%
1 Month Performance	-20.86%	-7.81%	-1.92%	1.96%
1 Year Performance	-31.79%	-29.96%	36.03%	32.94%

Exponent Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EXPO Exponent	4.4995 of 5 stars	$54.05 +0.7%	$85.00 +57.3%	-31.0%	$2.63B	$582.01M	25.21	1,212	Insider Trade
VSEC VSE	4.4741 of 5 stars	$191.21 -1.0%	$239.13 +25.1%	+37.0%	$5.42B	$1.11B	80.68	1,600
FCN FTI Consulting	4.1607 of 5 stars	$158.95 -3.0%	$180.00 +13.2%	-9.1%	$4.94B	$3.79B	18.90	8,118	Insider Trade
IHS IHS	2.3058 of 5 stars	$8.25 +0.1%	$9.61 +16.5%	+34.8%	$2.76B	$1.58B	20.11	2,762	News Coverage Earnings Report Upcoming Earnings Analyst Upgrade
HURN Huron Consulting Group	4.7276 of 5 stars	$115.94 -3.4%	$205.50 +77.2%	-29.8%	$1.94B	$1.70B	19.78	8,610	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EXPO) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Exponent (EXPO) Competitors